Komodo Health Launches MapLab Enterprise to Accelerate Healthcare Insights

What You Should Know:  – Komodo Health launches MapLab Enterprise, a powerful, full-stack analytics platform designed to transform how Healthcare and Life Sciences organizations generate and operationalize healthcare insights.  – The new platform empowers diverse teams—from data scientists to business executives—to collaborate seamlessly, accelerate time to insight, and make faster, more confident decisions based on ... Read More

Jun 10, 2025 - 23:10
 0
Komodo Health Launches MapLab Enterprise to Accelerate Healthcare Insights
Komodo Health Launches MapLab Enterprise to Accelerate Healthcare Insights

What You Should Know: 

Komodo Health launches MapLab Enterprise, a powerful, full-stack analytics platform designed to transform how Healthcare and Life Sciences organizations generate and operationalize healthcare insights. 

– The new platform empowers diverse teams—from data scientists to business executives—to collaborate seamlessly, accelerate time to insight, and make faster, more confident decisions based on unified healthcare data.

From Months to Hours: Accelerating Insights and Reducing Costs

Life Sciences teams typically face an average of seven months to generate actionable insights due to fragmented data, disconnected tools, and siloed teams. MapLab Enterprise directly addresses these challenges by providing a comprehensive analytics platform built on weekly refreshed views of over 330 million de-identified U.S. patient journeys, delivering immediate value without complex integration. By creating a unified analytics environment, MapLab Enterprise breaks down traditional barriers between data, analytics, and business teams, enabling organizations to standardize their data foundation and accelerate insight generation from months to mere hours.

“With MapLab Enterprise, projects that previously took six to eight weeks and cost over $250,000 can now be completed in a matter of hours, yielding immediate and actionable insights,” said Web Sun, President and Co-Founder of Komodo Health. “This allows our customers to make strategic decisions faster, improve patient lives sooner, and gain a competitive advantage from day one.”

MapLab Enterprise is deployable on demand and delivers substantial improvements across several critical dimensions:

  • Cost Reduction & Accelerated Insights: Reduces project timelines from months to days and delivers over 50% in cost savings through tools like MapAI™ and prebuilt analytics templates.
  • Near Real-Time Actionable Insights: Weekly data refreshes and scheduled analytics can drive significant lifts in script volume (up to 45%) and engagement rates (up to 3.8x) for personalized communications.
  • Unified Data Environment: Creates a single source of truth with standardized definitions and robust governance, reducing redundant cohort definitions by over 90%. It also supports the integration of first-, second-, and third-party data.
  • Flexible, Accessible Analytics: Customizes analytics for specific business needs with support for Python, SQL, and R, while democratizing insights across the organization.
  • Enterprise-Grade Security & Compliance: Built for privacy and scalability, the platform embraces open standards and offers full interoperability.
  • Foundation for Next-Generation AI: Provides the unified architecture required to build, train, and deploy next-generation, healthcare-specific AI models.

Tailored Solutions for the Healthcare Ecosystem

MapLab Enterprise offers specialized capabilities tailored to distinct market segments:

  • Commercial: A purpose-built solution to deliver actionable insights for launch tracking, HCP engagement, and gaining a competitive edge.
  • HEOR/RWE: Accelerates evidence generation through streamlined cohort definition, validation, and analysis, leveraging the Komodo Research Dataset (KRD).
  • Risk-Bearing Entities (RBEs): Delivers complete member histories and a secure architecture to minimize risk and accelerate market entry.

Financial Services: An essential intelligence platform for identifying market trends early, mitigating investment risk, and enhancing efficiency with weekly insights into brands, generics, and biosimilars.